Literature DB >> 20825409

Hydrogen sulphide induces mouse paw oedema through activation of phospholipase A2.

Roberta d'Emmanuele di Villa Bianca1, Ciro Coletta, Emma Mitidieri, Gianfranco De Dominicis, Antonietta Rossi, Lidia Sautebin, Giuseppe Cirino, Mariarosaria Bucci, Raffaella Sorrentino.   

Abstract

BACKGROUND AND
PURPOSE: Hydrogen sulphide (H(2)S), considered as a novel gas transmitter, is produced endogenously in mammalian tissue from L-cysteine by two enzymes, cystathionine β-synthase and cystathionine γ-lyase. Recently, it has been reported that H(2)S contributes to the local and systemic inflammation in several experimental animal models. We conducted this study to investigate on the signalling involved in H(2)S-induced inflammation. EXPERIMENTAL APPROACH: L-cysteine or sodium hydrogen sulphide (NaHS) was injected into the mouse hind paw and oedema formation was evaluated for 60 min. In order to investigate H(2)S-induced oedema formation, we used 5-HT and histamine receptor antagonists, and inhibitors of K(ATP) channels or arachidonic acid cascade. Prostaglandin levels were determined in hind paw exudates by radioimmunoassay. Paws injected with L-cysteine or NaHS were examined by histological methods. KEY
RESULTS: Both NaHS and L-cysteine caused oedema characterized by a fast onset which peaked at 30 min. This oedematogenic action was not associated with histamine or 5-HT release or K(ATP) channel activation. However, oedema formation was significantly inhibited by the inhibition of cyclooxygenases and selective inhibition of phospholipase A(2). Prostaglandin levels were significantly increased in exudates of hind paw injected with NaHS or L-cysteine. The histological examination clearly showed an inflammatory state with a loss of tissue organization following NaHS or L-cysteine injection. CONCLUSIONS AND IMPLICATIONS: Phospholipase A(2) and prostaglandin production are involved in pro-inflammatory effects of H(2)S in mouse hind paws. The present study contributes to the understanding of the role of L-cysteine/H(2)S pathway in inflammatory disease.
© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20825409      PMCID: PMC3010586          DOI: 10.1111/j.1476-5381.2010.01016.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Effect of crotapotin and heparin on the rat paw oedema induced by different secretory phospholipases A2.

Authors:  E C Landucci; M Toyama; S Marangoni; B Oliveira; G Cirino; E Antunes; G de Nucci
Journal:  Toxicon       Date:  2000-02       Impact factor: 3.033

2.  Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid.

Authors:  L L Thomsen; L M Ching; B C Baguley
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

3.  Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis.

Authors:  Ying-Yuan Pamela Mok; Mohammed Shirhan Bin Mohammed Atan; Cheong Yoke Ping; Wang Zhong Jing; Madhav Bhatia; Shabbir Moochhala; Philip K Moore
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

4.  H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms.

Authors:  Weimin Zhao; Rui Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08       Impact factor: 4.733

5.  Changes in arterial hydrogen sulfide (H(2)S) content during septic shock and endotoxin shock in rats.

Authors:  Yan Hui; Junbao Du; Chaoshu Tang; Geng Bin; Hongfeng Jiang
Journal:  J Infect       Date:  2003-08       Impact factor: 6.072

6.  Time courses of the anti-anaphylactic and anti-inflammatory effects of dexamethasone in the rat and mouse.

Authors:  M K Church; P Miller
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

7.  Preliminary studies on phospholipase A2-induced mouse paw edema as a model to evaluate antiinflammatory agents.

Authors:  L A Marshall; J Y Chang; W Calhoun; J Yu; R P Carlson
Journal:  J Cell Biochem       Date:  1989-06       Impact factor: 4.429

8.  Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression.

Authors:  Inmaculada Posadas; Mariarosaria Bucci; Fiorentina Roviezzo; Antonietta Rossi; Luca Parente; Lidia Sautebin; Giuseppe Cirino
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 9.  Hydrogen sulfide and substance P in inflammation.

Authors:  Madhav Bhatia
Journal:  Antioxid Redox Signal       Date:  2010-05-15       Impact factor: 8.401

10.  Thrombin functions as an inflammatory mediator through activation of its receptor.

Authors:  G Cirino; C Cicala; M R Bucci; L Sorrentino; J M Maraganore; S R Stone
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  9 in total

1.  Inhibitory action of novel hydrogen sulfide donors on bovine isolated posterior ciliary arteries.

Authors:  Madhura Kulkarni-Chitnis; Ya Fatou Njie-Mbye; Leah Mitchell; Jenaye Robinson; Matthew Whiteman; Mark E Wood; Catherine A Opere; Sunny E Ohia
Journal:  Exp Eye Res       Date:  2015-04-04       Impact factor: 3.467

2.  Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia.

Authors:  Roberta d'Emmanuele di Villa Bianca; Emma Mitidieri; Matteo N D Di Minno; Nicholas S Kirkby; Timothy D Warner; Giovanni Di Minno; Giuseppe Cirino; Raffaella Sorrentino
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

3.  Beneficial Effect of H2S-Releasing Molecules in an In Vitro Model of Sarcopenia: Relevance of Glucoraphanin.

Authors:  Laura Micheli; Emma Mitidieri; Carlotta Turnaturi; Domenico Vanacore; Clara Ciampi; Elena Lucarini; Giuseppe Cirino; Carla Ghelardini; Raffaella Sorrentino; Lorenzo Di Cesare Mannelli; Roberta d'Emmanuele di Villa Bianca
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

Review 4.  Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Authors:  Gregory J Weber; Sathnur Pushpakumar; Suresh C Tyagi; Utpal Sen
Journal:  Pharmacol Res       Date:  2016-09-04       Impact factor: 7.658

5.  Annexin A1 mediates hydrogen sulfide properties in the control of inflammation.

Authors:  Vincenzo Brancaleone; Emma Mitidieri; Roderick J Flower; Giuseppe Cirino; Mauro Perretti
Journal:  J Pharmacol Exp Ther       Date:  2014-07-30       Impact factor: 4.030

Review 6.  Gas what: NO is not the only answer to sexual function.

Authors:  G Yetik-Anacak; R Sorrentino; A E Linder; N Murat
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

7.  Effect of chlorogenic acid (5-Caffeoylquinic Acid) isolated from Baccharis oxyodonta on the structure and pharmacological activities of secretory phospholipase A2 from Crotalus durissus terrificus.

Authors:  Daniela O Toyama; Marcelo J P Ferreira; Paulete Romoff; Oriana A Fávero; Henrique H Gaeta; Marcos H Toyama
Journal:  Biomed Res Int       Date:  2014-09-02       Impact factor: 3.411

8.  Human Cystathionine-β-Synthase Phosphorylation on Serine227 Modulates Hydrogen Sulfide Production in Human Urothelium.

Authors:  Roberta d'Emmanuele di Villa Bianca; Emma Mitidieri; Davide Esposito; Erminia Donnarumma; Erminia Donnarumm; Annapina Russo; Ferdinando Fusco; Angela Ianaro; Vincenzo Mirone; Giuseppe Cirino; Giulia Russo; Raffaella Sorrentino
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

9.  An evaluation of 3-rhamnosylquercetin, a glycosylated form of quercetin, against the myotoxic and edematogenic effects of sPLA 2 from Crotalus durissus terrificus.

Authors:  Daniela de Oliveira Toyama; Henrique Hessel Gaeta; Marcus Vinícius Terashima de Pinho; Marcelo José Pena Ferreira; Paulete Romoff; Fábio Filippi Matioli; Angelo José Magro; Marcos Roberto de Mattos Fontes; Marcos Hikari Toyama
Journal:  Biomed Res Int       Date:  2014-02-18       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.